ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

RANI Rani Therapeutics Holdings Inc

7,72
0,57 (7,97%)
Nach Börsenschluss
Zuletzt aktualisiert: 00:11:53
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Rani Therapeutics Holdings Inc RANI NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,57 7,97% 7,72 00:11:53
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
7,08 6,90 7,7199 7,56 7,15
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
06.5.202422:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.5.202422:05GLOBERani Therapeutics Reports First Quarter 2024 Financial..
06.5.202422:04EDGAR2Form 8-K - Current report
20.3.202421:05GLOBERani Therapeutics Reports Fourth Quarter and Full Year 2023..
15.3.202421:05GLOBERani Therapeutics to Report Fourth Quarter and Full Year..
05.2.202414:10EDGAR2Form 8-K - Current report
05.2.202414:00GLOBERani Therapeutics Announces Positive Topline Results from..
19.12.202322:06EDGAR2Form 8-K - Current report
19.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.12.202314:05EDGAR2Form 8-K - Current report
14.12.202314:00GLOBERani Therapeutics Announces Preclinical Pharmacodynamic Data..
07.12.202323:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.12.202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.11.202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.11.202322:10EDGAR2Form 8-K - Current report
08.11.202322:05GLOBERani Therapeutics Reports Third Quarter 2023 Financial..
01.11.202321:05GLOBERani Therapeutics Announces Strategic Program..
01.11.202321:04EDGAR2Form 8-K - Current report
25.10.202314:03EDGAR2Form 8-K - Current report
25.10.202314:00GLOBEThe RaniPill® Capsule, Rani Therapeutics’ Oral Delivery..
19.10.202322:05GLOBERani Therapeutics Announces Successful Oral Delivery of..
12.10.202322:05GLOBERani Therapeutics to Present Abstract on RT-102 at the 2023..
18.9.202314:00GLOBERani Therapeutics Initiates Phase 1 Study of RT-111..
07.9.202323:04EDGAR2Form 8-K - Current report
07.9.202322:05GLOBERani Therapeutics Announces Successful Drug Delivery of..
06.9.202314:00GLOBERani Therapeutics to Participate in September Investor..
11.8.202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11.8.202322:05GLOBERani Therapeutics Reports Second Quarter 2023 Financial..
08.8.202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.8.202322:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
04.8.202322:05GLOBERani Therapeutics to Participate in August Investor..
21.6.202314:00GLOBERani Therapeutics’ Presentation On Oral Delivery of PTH for..
08.6.202314:00GLOBERani Therapeutics Announces Acceptance of Late-Breaking..
05.6.202314:00GLOBERani Therapeutics and Celltrion Expand Partnership to..
01.6.202314:00GLOBERani Therapeutics to Present at the Jefferies Healthcare..
31.5.202314:00GLOBERani Therapeutics Announces Acceptance of Three Abstracts..
24.5.202314:00GLOBERani Therapeutics Appoints Kate McKinley as Chief Business..
10.5.202322:05GLOBERani Therapeutics Reports First Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock